[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE53944T1 - Waessrige fluessige zubereitungen. - Google Patents

Waessrige fluessige zubereitungen.

Info

Publication number
ATE53944T1
ATE53944T1 AT86111306T AT86111306T ATE53944T1 AT E53944 T1 ATE53944 T1 AT E53944T1 AT 86111306 T AT86111306 T AT 86111306T AT 86111306 T AT86111306 T AT 86111306T AT E53944 T1 ATE53944 T1 AT E53944T1
Authority
AT
Austria
Prior art keywords
aqueous liquid
liquid preparations
irritation
compound
heightened
Prior art date
Application number
AT86111306T
Other languages
English (en)
Inventor
Hisayoshi Shimizu
Mitsuaki Oshima
Hideo Terayama
Original Assignee
Takeda Chemical Industries Ltd
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, Senju Pharma Co filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE53944T1 publication Critical patent/ATE53944T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT86111306T 1985-08-19 1986-08-15 Waessrige fluessige zubereitungen. ATE53944T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18238385 1985-08-19
EP86111306A EP0213514B1 (de) 1985-08-19 1986-08-15 Wässrige flüssige Zubereitungen

Publications (1)

Publication Number Publication Date
ATE53944T1 true ATE53944T1 (de) 1990-07-15

Family

ID=16117350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86111306T ATE53944T1 (de) 1985-08-19 1986-08-15 Waessrige fluessige zubereitungen.

Country Status (10)

Country Link
US (1) US4728509A (de)
EP (1) EP0213514B1 (de)
JP (1) JPS62123116A (de)
AT (1) ATE53944T1 (de)
CA (1) CA1269618A (de)
DE (1) DE3672097D1 (de)
DK (1) DK166757B1 (de)
IE (1) IE59425B1 (de)
MY (1) MY102075A (de)
NO (1) NO171005C (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4778810A (en) * 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5602112A (en) 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
EP0621036B1 (de) * 1993-04-22 1999-03-17 Senju Pharmaceutical Co., Ltd. Wässrige Arzneizubereitungen enthaltend Argatroban und Cyclodextrin oder Coffein
US5519030A (en) * 1993-10-07 1996-05-21 Senju Pharmaceutical Co., Ltd. Method for prophylaxis and treatment of myopia
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US5952338A (en) * 1996-07-05 1999-09-14 Takeda Chemical Industries, Ltd. Agent for prophylaxis and treatment of disturbance of visual function
JP4439596B2 (ja) * 1997-06-13 2010-03-24 サイデクス ファーマシューティカルズ、 インク. 長期の貯蔵寿命を有する、極性薬物又は極性プロドラッグを含有する医薬組成物、及びその製造方法
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
CA2342797A1 (en) 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
EP1312380B1 (de) * 2000-06-19 2006-05-03 Santen Pharmaceutical Co., Ltd. Aseptische mittel
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
TR201820559T4 (tr) 2004-11-24 2019-01-21 Meda Pharmaceuticals Inc Azelastin içeren kompozisyonlar ve bunların kullanım metotları.
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
WO2006099359A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070009531A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010466A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
SI2493474T1 (sl) * 2009-10-30 2019-11-29 Intratus Inc Postopki in sestavki za trajno dovajanje zdravil
CN103140215A (zh) * 2010-07-21 2013-06-05 爱尔康研究有限公司 具有提高的溶解度特征的药物组合物
US10245255B2 (en) 2011-02-14 2019-04-02 The Regents Of The University Of Michigan Compositions and methods for the treatment of obesity and related disorders
CN103998046B (zh) 2011-11-29 2021-04-06 优奥斯私人有限公司 包含环糊精和疏水性药物的可注射药物组合物的防腐方法
US9365581B2 (en) 2013-05-02 2016-06-14 The Regents Of The University Of Michigan Deuterated amlexanox
EP3407974A4 (de) 2016-01-29 2019-08-28 The Regents Of The University Of Michigan Amlexanox-analoga
EP3505154B1 (de) * 2017-12-26 2022-04-06 Industrial Technology Research Institute Zusammensetzung zur verbesserung der löslichkeit schwerlöslicher substanzen, ihre verwendung und diese enthaltende komplexe formulierung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD7498A1 (de) * 1951-02-20 1954-05-31 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von haltbaren Lösungen in 1,3-Stellung substituierter Xanthine
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
JPS53111096A (en) * 1977-03-08 1978-09-28 Takeda Chem Ind Ltd 1-azaxanthone-3-carboxylic acid derivative and its preparation
US4143042A (en) * 1977-03-08 1979-03-06 Takeda Chemical Industries, Ltd. 1-azaxanthone-3-carboxylic acids
JPS54115398A (en) * 1978-02-27 1979-09-07 Takeda Chem Ind Ltd 1-azaxanthone-3-carboxylic acid derivative and its preparation
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
ZA815175B (en) * 1980-08-01 1982-09-29 Smith & Nephew Ass Pharmaceutical composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤
DE3372705D1 (en) * 1982-04-30 1987-09-03 Takeda Chemical Industries Ltd Pharmaceutical composition and its use
US4539326A (en) * 1982-08-20 1985-09-03 Takeda Chemical Industries, Ltd. 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
JPS59106424A (ja) * 1982-12-09 1984-06-20 Kyorin Pharmaceut Co Ltd 易吸収性キノリンカルボン酸誘導体組成物およびその製剤
JPS59152320A (ja) * 1983-02-17 1984-08-31 Takeda Chem Ind Ltd 水性製剤
KR920010047B1 (ko) * 1985-01-28 1992-11-13 다께다야꾸힝고오교 가부시끼가이샤 2-아미노-5-옥소-5H-[1]벤조피라노[2,3-b]피리딘-3-카르복실산 유도체의 제조방법

Also Published As

Publication number Publication date
DE3672097D1 (de) 1990-07-26
NO863253D0 (no) 1986-08-12
DK166757B1 (da) 1993-07-12
EP0213514A2 (de) 1987-03-11
JPH0478614B2 (de) 1992-12-11
NO863253L (no) 1987-02-20
IE59425B1 (en) 1994-02-23
MY102075A (en) 1992-03-31
NO171005B (no) 1992-10-05
DK379986A (da) 1987-02-20
US4728509A (en) 1988-03-01
DK379986D0 (da) 1986-08-08
JPS62123116A (ja) 1987-06-04
EP0213514A3 (en) 1987-07-22
CA1269618A (en) 1990-05-29
NO171005C (no) 1993-01-13
EP0213514B1 (de) 1990-06-20
IE862214L (en) 1987-02-19

Similar Documents

Publication Publication Date Title
ATE53944T1 (de) Waessrige fluessige zubereitungen.
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
KR880001651A (ko) 이미다조 [4,5-b] 피리딘 유도체, 그의 제조방법 및 그를 함유하는 항궤양제
JPS5297950A (en) Chalconeether derivatives
ES2063452T3 (es) Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos.
DK328188A (da) Pyridinderivater, deres fremstilling og laegemidler indeholdende forbindelserne
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR880011155A (ko) 이미다조피리딘유도체, 그의 제법 및 치료에의 응용
KR890008110A (ko) 피리미딘 유도체
KR850006191A (ko) 티오시아노 피리미딘 유도체의 제조방법
DE3882623D1 (de) Phosphorsaeurediester und salze davon.
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof
JPS5424829A (en) Organic phosphate compound, its preparation, and insecticide, miticide and nematocide containing the same
ES2001676A6 (es) Procedimiento para la preparacion de derivados propionamidinos
AU566243B2 (en) Optically active imidazolylpropanols
ATE53163T1 (de) Desinfektionszusammensetzungen.
AU2639388A (en) 2-cyano-2-aryl-1-(azole-1-yl)- ethane derivatives
JPS53130655A (en) Methyl-n-acylanthranylate derivative, its preparation, and agaicultural and horticultural fungicide containing the same
JPS53147017A (en) Compound of acylketene-s.n-acetal and its preparation
JPS5283571A (en) Glutarimide derivatives
IL108225A (en) 2-THIENYLIMIDAZO £2, 1-b| BENZOTHIAZOLE-3-ACETIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR860006209A (ko) 제초제 조성물
DE3572670D1 (de) 13-alpha-alkyl-17-beta-(3-acyloxy-propyl)-gonane
JPS52122387A (en) 7alpha-methoxycephalosporin derivatives and their preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee